Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement

Article English OPEN
Spuls, P. I.; Gerbens, L. A.A.; Simpson, E.; Apfelbacher, C. J.; Chalmers, J. R.; Thomas, K. S.; Prinsen, C. A.C.; von Kobyletzki, L. B.; Singh, J. A.; Williams, H. C.; Schmitt, J.;

Background: The Harmonising Outcome Measures for Eczema (HOME) initiative has defined four core outcome domains for a core outcome set (COS) to be measured in all atopic eczema (AE) trials to ensure cross-trial comparison: clinical signs, symptoms, quality of life and l... View more
  • References (16)
    16 references, page 1 of 2

    1. Roekevisch E, Spuls P, Kuester D, et al. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review. J Allergy Clin Immunol. 2014;133(2):429- 38.

    2. Schmitt J, Williams H, Home Development Group. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, Munich, Germany. The British journal of dermatology. 2010;163(6):1166-8.

    3. Schmitt J, Langan S, Stamm T, et al. Core outcome domains for controlled trials and clinical recordkeeping in eczema: International Multiperspective Delphi Consensus Process. J Invest Dermatol. 2011;131(3):623-30.

    4. Schmitt J, Spuls P, Boers M, et al. Towards global consensus on outcome measures for atopic eczema research: Results of the HOME II meeting. Allergy Eur J Allergy Clin Immunol. 2012;67(9):1111-7.

    5. Chalmers J, Schmitt J, Apfelbacher C, et al. Report from the third international consensus meeting to harmonise core outcome measures for atopic eczema/dermatitis clinical trials (HOME). Br J Dermatol. 2014;171(6):1318-25.

    6. Williamson P, Altman D, Blazeby J, et al. Developing core outcome sets for clinical trials: Issues to consider. Trials. 2012;13.

    7. Schmitt J, Apfelbacher C, Spuls P, et al. The Harmonizing Outcome Measures for Eczema (HOME) Roadmap: A Methodological Framework to Develop Core Sets of Outcome Measurements in Dermatology. J Invest Dermatol. 2015;135(1):24-30.

    8. Boers M, Brooks P, Strand C, et al. The OMERACT filter for Outcome Measures in Rheumatology. J Rheumatol. 1998;25(2):198-9.

    9. Schmitt J, Langan S, Deckert S, et al. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. The Journal of allergy and clinical immunology. 2013;132(6):1337-47.

    10. Schmitt J, Spuls PI, Thomas KS, et al. The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials. The Journal of allergy and clinical immunology. 2014;134(4):800-7.

  • Metrics
Share - Bookmark